Illumina Appeals FTC’s Ruling to Divest Grail

Fresh off a proxy battle, Illumina has filed an appeal against an FTC order that would have it divest Grail, an early cancer detection company.

In the appeal, Illumina is arguing that FTC "violated due process by depriving Illumina and Grail of a fair proceeding before an impartial tribunal," according to a report from Reuters citing a filing in the U.S. Fifth Circuit Court of Appeals.